Home Newsfeeds Jefferies Downgrades Mesoblast to Hold

Jefferies Downgrades Mesoblast to Hold

Jefferies analyst David Stanton downgrades Mesoblast (NASDAQ:MESO) from Buy to Hold.

byBenzinga Newsdesk

December 6, 2022

1 minute read

Jefferies analyst David Stanton downgrades Mesoblast (NASDAQ:MESO) from Buy to Hold.

Bitcoin, Ethereum, Dogecoin Decline As $100M Vanishes In A Single Day Amid Israel-Palestinian Conflict: Analyst Says ETH, BTC Are ‘Getting Slaughtered’

By Mehab Qureshi

October 9, 11:04 PM

Major cryptocurrencies plunged on Monday evening following an escalation in the Israeli-Palestinian conflict over the weekend.

$DOGE

Analyst Ratings

Demystifying Opendoor Technologies: Insights From 4 Analyst Reviews

By Benzinga Insights

January 3, 11:00 AM

Throughout the last three months, 4 analysts have evaluated Opendoor Technologies (NASDAQ:OPEN), offering a diverse set of opinions…

OPEN

XPeng Fears Tariff Hike In Europe, Reportedly Considers Investing Abroad

By Shivani Kumaresan

April 25, 11:36 AM

As the European Commission investigates Chinese EVs, XPeng weighs overseas production options amidst regulatory adjustments. Brian Gu, co-president of Volkswagen-backed XPeng, reports potential shifts in strategy amid evolving regulations. With eyes on a 10% international sales boost, XPeng targets US market entry despite challenges.

VWAGY